Wertpapierdatensatz · archiviertes Quartal
IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
15Erfasste Halter
0Δ Inhaber
77.60MGehaltene Aktien
$190.89MGemeldeter Wert
+2Neue Positionen
−2Ausstiege
Momentum-Eingaben (vergleichbare Manager): Halterbreite 0.0% · Aktienfluss +19.4% · neue Nettopositionen 0.0% — Formel
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 105 | +5 | 153.88M | $1.35B | +10 | −5 |
| Q1 2026 | 103 | +11 | 130.83M | $998.92M | +19 | −8 |
| Q4 2025 | 91 | -1 | 143.54M | $283.94M | — | −1 |
| Q3 2025 | 15 | 0 | 77.60M | $190.89M | +2 | −2 |
| Q2 2025 | 12 | +1 | 58.35M | $154.05M | +1 | — |
| Q1 2025 | 8 | 0 | 12.96M | $39.01M | +1 | −1 |
| Q4 2024 | 8 | +1 | 14.27M | $36.54M | +2 | −1 |
| Q3 2024 | 6 | 0 | 5.93M | $22.06M | +1 | −1 |
| Q2 2024 | 6 | — | 4.42M | $27.95M | — | — |
Wer es hält · Q3 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (passiv) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passiv) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passiv) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passiv) | 27.66M | +26.8% | $68.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | BlackRock ✦ (passiv) | 19.81M | +11.5% | $48.73M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (passiv) | 11.32M | +48.6% | $27.84M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passiv) | 6.89M | +19.3% | $16.95M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Geode Capital Management ✦ (passiv) | 6.89M | +19.3% | $16.95M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 20 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Morgan Stanley ✦ | 3.37M | — | $8.30M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Two Sigma Investments ✦ | 2.61M | +224.9% | $6.42M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 28 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 29 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 30 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 33 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 34 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 35 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 36 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 37 | JPMorgan Chase ✦ | 2.12M | — | $5.21M | 0.0% | n/c | 1 | SEC ↗ |
| 38 | Goldman Sachs Group ✦ | 1.14M | — | $2.81M | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Goldman Sachs Group ✦ | 1.14M | — | $2.81M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Citadel Advisors ✦ | 1.13M | +43.8% | $2.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 41 | Citadel Advisors ✦ | 1.13M | +43.8% | $2.78M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 42 | Renaissance Technologies ✦ | 1.02M | Neu | $2.50M | 0.0% | New | 1 | SEC ↗ |
| 43 | Marshall Wace ✦ | 254.81K | Neu | $626,844 | 0.0% | New | 1 | SEC ↗ |
| 44 | T. Rowe Price ✦ | 121.05K | +5.3% | $298,000 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 47 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 48 | AQR Capital Management ✦ | 103.78K | -34.8% | $255,296 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 49 | Millennium Management ✦ | 48.30K | -98.5% | $118,808 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 50 | Fidelity (FMR) ✦ | 10.91K | -22.8% | $26,848 | 0.0% | ▼ Trim | 2 | SEC ↗ |
„Ihre Gewichtung" = Anteil der Position am gemeldeten 13F-Eigenkapitalwert des jeweiligen Managers — das Conviction-Maß. ✦ = kuratorisch ausgewählter Manager.
Neue Käufer
| Renaissance Technologies | $2.50M | 0.0% |
| Marshall Wace | $626,844 | 0.0% |
Ausgestiegen
| D. E. Shaw & Co. | $626,068 | war 0.0% |
| Gotham Asset Management | $42,831 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 383 Inhaber, 176.43M Anteile, $1.31B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten — Zählungen gemeinsamer Eigentümerschaft, keine fundamentalen Zusammenhänge.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q3 2025 ·
Methodik ·
Über die API abrufen